Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCSW) Change in Account Payables (2021 - 2025)

Historic Change in Account Payables for HeartSciences (HSCSW) over the last 5 years, with Q4 2025 value amounting to $34165.0.

  • HeartSciences' Change in Account Payables rose 12855.22% to $34165.0 in Q4 2025 from the same period last year, while for Oct 2025 it was $40542.0, marking a year-over-year increase of 10499.62%. This contributed to the annual value of -$129522.0 for FY2025, which is 2929.48% up from last year.
  • Per HeartSciences' latest filing, its Change in Account Payables stood at $34165.0 for Q4 2025, which was up 12855.22% from -$35436.0 recorded in Q3 2025.
  • HeartSciences' Change in Account Payables' 5-year high stood at $633457.0 during Q4 2023, with a 5-year trough of -$673221.0 in Q1 2024.
  • Over the past 5 years, HeartSciences' median Change in Account Payables value was -$28194.0 (recorded in 2022), while the average stood at $22031.1.
  • Its Change in Account Payables has fluctuated over the past 5 years, first soared by 97047.24% in 2023, then crashed by 37431.27% in 2024.
  • Quarter analysis of 5 years shows HeartSciences' Change in Account Payables stood at $167025.0 in 2021, then soared by 103.28% to $339522.0 in 2022, then skyrocketed by 86.57% to $633457.0 in 2023, then tumbled by 118.89% to -$119658.0 in 2024, then surged by 128.55% to $34165.0 in 2025.
  • Its Change in Account Payables was $34165.0 in Q4 2025, compared to -$35436.0 in Q3 2025 and -$86415.0 in Q2 2025.